Sogawa K, Yamada T, Sugita A, Kito K, Tachibana M, Nezu K, Ueda N
Department of Pathology, University of Ehime School of Medicine, Japan.
Res Commun Mol Pathol Pharmacol. 1996 Jul;93(1):33-42.
The expression of the three catalytic subunits of protein phosphatase (PP) type 1 and 2A, PP1 alpha, PP1 gamma 1, and PP2AC, was examined in osteogenic tumors and soft tissue tumors by immunohistochemical analysis. The percentage of cells stained positively with antiserum against PP1 catalytic subunit isoform PP1 gamma 1, was significantly higher in malignant osteogenic tumors (chondrosarcoma, osteosarcoma, and Ewing's sarcoma) and in malignant soft tissue tumors (liposarcoma and malignant fibrous histiocytoma [M.F.H.]) than in benign tumors (osteochondroma, osteoblastoma, ossifying fibroma, enchondroma and lipoma). Furthermore, the malignant tumor lesions showed a markedly high number of cells in the S-phase fraction of the cell cycle, as compared to benign tumors. These results suggest that PP1 gamma 1 is involved in the accelerated growth of malignant tumor cells.
通过免疫组织化学分析,检测了蛋白磷酸酶(PP)1型和2A型的三种催化亚基PP1α、PP1γ1和PP2AC在成骨性肿瘤和软组织肿瘤中的表达。在恶性成骨性肿瘤(软骨肉瘤、骨肉瘤和尤因肉瘤)以及恶性软组织肿瘤(脂肪肉瘤和恶性纤维组织细胞瘤[M.F.H.])中,用抗PP1催化亚基异构体PP1γ1的抗血清染色呈阳性的细胞百分比,显著高于良性肿瘤(骨软骨瘤、成骨细胞瘤、骨化性纤维瘤、内生软骨瘤和脂肪瘤)。此外,与良性肿瘤相比,恶性肿瘤病变在细胞周期的S期部分显示出明显更多的细胞。这些结果表明,PP1γ1参与了恶性肿瘤细胞的加速生长。